共 50 条
Center for Personalized Precision Medicine for Tuberculosis: Smart Research and Development Workstation
被引:2
|作者:
Van Lam Nguyen
[1
,2
,3
]
Ahn, Sangjin
[1
]
Pham Quang Hoa
[1
,2
,3
]
Nguyen Phuoc Long
[1
,2
,3
]
Ahn, Sangzin
[1
,2
,3
]
Cho, Yong-Soon
[1
,2
,3
,4
]
Shin, Jae-Gook
[1
,2
,3
,4
]
机构:
[1] Inje Univ, Ctr Personalized Precis Med TB, Coll Med, Busan, South Korea
[2] Inje Univ, Dept Pharmacol, Coll Med, 75 Bokji Ro, Busan 47392, South Korea
[3] Inje Univ, Pharmacogen Res Ctr, Coll Med, 75 Bokji Ro, Busan 47392, South Korea
[4] Inje Univ, Dept Clin Pharmacol, Busan Paik Hosp, Busan, South Korea
基金:
新加坡国家研究基金会;
关键词:
ANTITUBERCULOSIS DRUGS;
D O I:
10.4258/hir.2022.28.2.176
中图分类号:
R-058 [];
学科分类号:
摘要:
Tuberculosis is an important global public health problem. Ranked above HIV/AIDS, it is considered the leading cause of death by a single infectious agent. According to the Global Tuberculosis Report 2020, tuberculosis causes 1.3 million deaths per year [1]. Although the mortality and incidence rates of tuberculosis in Korea have steadily decreased in recent years [2], the management of tuberculosis remains challenging and requires more effective efforts. In clinical settings, inadequate treatment leading to therapeutic failure and drug resistance was reported as a major challenge in tuberculosis management efforts [3,4]. Therefore, precision tuberculosis treatment strategies should be deployed to reach the global tuberculosis control targets.
引用
收藏
页码:176 / 180
页数:5
相关论文